Seeking AlphaThu, 09 Apr 2026 23:42:02 GMTInvivyd, Inc. (IVVD) Discusses Progress in REVOLUTION Clinical Program and Advancement of Measles Monoclonal Antibody Candidate TranscriptIVVD-1.34%
BenzingaThu, 09 Apr 2026 14:07:27 GMTInvivyd Stock Surges As FDA Alignment Boosts COVID-19 ProgramIVVD-1.34%
Seeking AlphaFri, 20 Mar 2026 15:22:25 GMTInvivyd: A Logical Bull Thesis With A Major Catalyst ApproachingIVVD-1.34%
Seeking AlphaThu, 05 Mar 2026 16:25:58 GMTInvivyd, Inc. (IVVD) Q4 2025 Earnings Call TranscriptIVVD-1.34%